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The presence of extended-spectrum- β lactamases (ESBLs) in a clinical infection can result in 
treatment failure if one of the third-generation cephalosporins is used. ESBLs detection has 
both clinical as well as epidemiological relevance. The present study was conducted to detect 
the frequency of ESBL producing pathogens that causes wound infections. Hundred wound 
samples were collected from Khartoum state Hospitals were investigated for isolation and 
identification (colonial characteristics, Gram reaction, biochemical reactions, and antibiotic 
susceptibility). The frequency of isolates from all cases was 95 (95%) with 5 (5%) yielding 
no growth. The isolates were E.coli, Klebsiella species, staph aureus, Proteus species and 
Pseudomonas aeruginosa which isolated from 27(28.4%), 13(13.68%), 23(24.21%), 
20(21.05%) and 12(12.63%) respectively. The isolates were subjected to show their 
susceptibility against the third generation cephalosporins (Cefotaxime, Ceftazidime and 
Ceftriaxone) using disk diffusion method. The results were observed that 60(63.1%) out of 95 
isolates shown resistance to third generation cephalosporins, while35 isolates were sensitive 
to these antibiotics. The sixty resistant isolates were subjected to show their ability to produce 
ESBL using Kirby _Bauer Method (Calvulanic acid + Third generation cephalosporins).  
Among 18 E.coli, 4 Klebsiella species, 16 Staph aureus, 12 Proteus species, 10 Pseudomonas 
aeruginosa, isolates which were tested, 6(33.33%), 1(25%), 9(56.2%), 3(30%) and 3(30%) 
were found to be ESBL producer respectively. We conclude that the ESBL producers were 
found in large proportions which may refers to misusing of antibiotics or inadequate 
treatment. 
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Introduction        
Wound is a breach in the skin and exposure to subcutaneous tissue following loss of skin 
integrity providing a moist, warm and nutritive environment that is conductive for 
colonization and proliferation of opportunistic and pathogenic microorganism. 
Wounds can be classified into two types (a) open wounds which include incisions, lacerations 
puncture wounds, gunshot wounds and abrasions. (b) Closed wounds which include 
contusions more commonly known as bruises, hematomas crush injury (1).  
Beta lactamases are enzymes produced by bacteria that inactivate either penicillin or 
cephalosporins, but some can inactivate both classes of drugs. Most Gram positive bacteria 
secrete beta-lactamases so that beta-lactam drugs are inactivated extracellulry, i.e., in the 
surrounding medium. By contrast, the beta-lactamase of gram negative remains inside the cell 
and inactivate beta lactm drugs in periplasmic space, i.e., the space between the outer 
membrane and cytoplasmic membrane (2). ESBLs are enzymes capable of hydrolyzing 
extended spectrum cephalosporins, penicillins and monobactam, but inactivated against 
cephamycin and imipenem. Wide spread use of third generation cephalosporins and 
azetronams is believed to be the major cause of the emergence of the ESBLs (3). 
The term ESBLs is used to mean acquired class A β-lactamases that hydrolyze and confer 
resistance to oxyimino- ‘2nd - and 3rd -generation’ cephalosporins, eg cefuroxime, cefotaxime, 
ceftazidime and ceftriaxone (4). 
Criteria: 
• Are capable of inactivating extended spectrum cephalosporins (first, second, third, 
fourth -generations and the monobactam aztreonam). 
•  Are inhibited by beta lactases inhibitors, such as clavulanic acid, cabapenem-
sulbactum, tozabactam and to temocillin (5). 
These new enzymes were given the name ESBLs that reflect the fact that they were the older 
beta lactamases and had a new capability to hydrolyze a broader spectrum of beta lactam 
drugs (6). 
ESBLs are not the only β-lactamases to confer resistance to 2nd and 3rd generation 
cephalosporins while sparing carbapenems, but are the most important. Moreover, as 
plasmid-mediated enzymes, they have great potential for spread. They occur mostly in 
Enterobacteriaceae (eg E.coli Klebsiella species and Enterobacter species) and rarely in non-
fermenters (eg P. aeruginosa). They should be distinguished from other important modes of 
resistance to 2nd and 3rd generation cephalosporins (7). 
The introduction of third-generation cephalosporins improved the effectiveness of therapy for 
the vast majority of infections caused by gram-negative bacteria; however, the use of these 
highly β-lactamase stable compounds has led to the emergence of resistant species(8). 
In Dhaka medical college, Bangladesh a total of 320 samples were collected during July 2010 
and June 2011 from the department of microbiology. Out of the 320 samples 169   (53%) 
gram negative bacteria were isolated, comprising 90(53%) E.coli, 25(15%)  K.pneumniae, 
15(9%) proteus spp and 39 (23%) pseudomonas spp. From the isolated gram negative 
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bacteria , 42 (25%) were ESBL producers detected by Double Disk Synergy test all of them 
were resistant to amoxicillin, azitroenam,  cephradine,  cefuroxime , cefotaxime , ceftraxione, 
and ceftazidime (9) .    
                     
Materials and Methods 
This was Descriptive-cross-sectional study which had been conducted in Khartoum state 
during September to December 2014, 100 wound infected patients were enrolled. Ethical 
clearance was taken from research committee of AL Neelain University and verbal consent 
was taken from each individual with wound infection. Data were analyzed by Excel and 
Statistical Analysis System (SAS) soft wire.  
Experimental Work  
Specimen's collection: 
Wound specimens were collected from 100 patients, under aseptic condition using sterile 
cotton swabs. 
Culture and identification: 
Wound specimens were inoculated onto blood agar and Macconkey media and incubated at 
37°C over night. The isolates were identified by observing morphology and using 
conventional biochemical tests. 
Antimicrobials susceptibility test 
An overnight culture suspension of the test isolates which was adjusted to 0.5 McFarland’s 
standard was inoculated by using a sterile cotton swab on the surface of a Mueller Hinton 
agar plate. A disc of 30-μg disc of Cefotaxime, Ceftazidime, and Ceftriaxone were placed 15 
mm apart. After incubating overnight at 37°C, the presence of inhibition zones of discs was 
interpreted as positive for 3rd-generation cephalosporins if the zone read more than 22 mm 
(10). 
Extended-spectrum β-lactamases’ (ESBLs) resistance detection 
Combination Disk Method 
The combination-disk test using Cefotaxime, Ceftazidime, and Ceftriaxone alone and in 
combination with clavulanic acid was performed for the detection of ESBL according to the 
CLSI guidelines. In this test, an overnight culture suspension of the test isolates which was 
adjusted to 0.5 McFarland’s standard was inoculated by using a sterile cotton swab on the 
surface of a Mueller Hinton Agar plate. The Cefotaxime (30 μg) and cefotaxime-clavulanic 
acid (30 μg/ 10 μg) disks were placed 20 mm apart on the agar,  ceftazidime (30 μg) and 
ceftazidime-clavulanic acid (30 μg / 10 μg) disks were placed 20 mm apart and 
Ceftriaxone(30 μg)and Ceftriaxone-clavulanic acid (30 μg / 10 μg) disks were placed 20 mm 
apart. After incubating overnight at 37°C, a ≥ 5-mm increase in the zone diameter for either 
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antimicrobial agent which will test in combination with clavulanic acid vs. its zone when test 





A total of 100 wound specimens which were collected from hospitals of Khartoum State – 
Sudan during september to December 2014. The frequency of isolates from all cases was 
95(95%) with 5(5%) showed no growth. Gram negative organisms accounted for 72(75.78%) 
of all isolates while gram positive accounted for 23(24.21%). Among gram negative 
organisms, Escherichia coli accounted for 27(28.4%), Klebseilla spps 13(13.68%), Proteus 
spps 20(21.05%) and Pseudomonas aeruginosa 12(12.63%), while Staphylococcus aureus 
was only gram positive isolate with a frequency of 23(24.21%) (Table 1). From these 95 
isolates 60(63.1%) microorganisms were showed resistance to third-generation 
cephalosporins and they were tested for the ESBL production and 35(36.8%) were sensitive 
to these antibiotics. These tested microorganisms exhibit resistance to the third-generation 
cephalosporins as E.coli 18 (30.00%), Klebseilla spps 4 (6.6%), Staph aureus16 (26.6%), 
Proteus spp 12 (20%), and Pseudomonas aeruginosa 10 (16.6%). Among these isolates, 6 out 
of 18 E.coli (33.33%), 1 out of 4 Klebseilla spps (25.00%), 9 out of 16 staph aureus (56.2%), 
3 out of 12 Proteus spps (25.00%), 3 out of 10 Pseudomonas aeruginosa (30%) were 
detected to be ESBL producers (table2). The overall of ESBL producers were 22 isolates 
(36.67%). Highest rate of ESBLS was observed in Staph aureus 9 (56.2%) out of 16, 
followed by E.coli 6 (33.33%) out of 18, Pseudomonas aeruginosa 3 (30%) out of 10, 





ESBL producing strains are gradually increasing, especially in nosocomial infections 
throughout the world. The occurrence of ESBL producers among clinical isolates vary greatly 
worldwide and are rapidly changing over time. Gram negative organisms accounted for four 
times the number of isolates than gram positive; this is in agreement to a similar study in 
Nigeria 2004 by Kehinde et al that reported a frequency of 72.0% for gram negative 
organisms and 28.0% for gram positive (11). 
 The isolated microorganisms are similar to the observation in some centers in Nigeria where 
Pseudomonas spp, Klebsiella spp, E. coli and Coliforms are the predominant pathogens 
responsible of wound and other nosocomial infections (12).The present study detect (21.6%) 
ESBL producing gram-negative bacteria which is closely simillar to Previous studies in 
Bangladesh which revealed 23% to 31% ESBL producers from gram-negative bacteria (13). 
However, the proportion of ESBL producers was reported as 80% in another study in 
Bangladesh (14). higher results of staph aurues (56.2%) which was the predominant ESBL 
American Journal of Research Communication                              www.usa-journals.com 
Elrahman, et al., 2015:  Vol 3(6)                        165                        ajrc.journal@gmail.com 
producers in this study is  higher than the reported result from government hospital in south 
India(37.7%) (15) , also in this study it found  33.33% E.coli , 25% Proteus spps and 25% 
Klebseilla spps were ESBL producer which similar to result from Bangladesh (32% ,20% and 















1 E.coli 27 28.4 
2 staph aureus 23 24.21 





















ESBL (no %) 
Negative 
ESBL (no %) 
total 
E.coli 6(33.33) 21(25) 27 
staph aureus 9(56.2) 14(23.3) 23 
Proteus spps 3(25) 17(28.33) 20 
Klebseilla spps 1(25) 12(20) 13 
Pseudomonas 
aeruginosa 
3(30) 9(15) 12 
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Figure (1): ESBL production by staph aureus to Ceftriaxone-clavulanic acid (CTC), 




The routine susceptibility tests by clinical laboratories fail to detect ESBL producer strains. 
The result presented in this study confirms that the most commonly used antibiotics against 
wound infections become increasingly resistant and it is the right time to ensure the judicial 
use of antibiotics, and treatment will be done by using carbapinim group of drugs .National 
committee of clinical laboratory standers (NCCLS) recommended that when ESBL 
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